Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday newspaper round-up: India-Pakistan, Drax Group, Shein

(Sharecast News) - Indian Navy ships test-fired missiles on Sunday to demonstrate the country's ability to launch "long-range, precision offensive" strikes. The move follows rising tensions with Pakistan after an attack on civilians at a tourist site in Kashmir. Also at the weekend, Pakistan's railway minister warned that Islamabad's arsenal of over 130 missiles was "not kept as models". - Guardian

Ed Miliband, the Energy Secretary, is being accused of complicity in polluting a town in Mississippi using UK taxpayers' cash. That is because Drax Group's power plant in North Yorkshire used wood pellets sourced in many instances from US forests to generate electricity. The company also receives billions in green energy subsidies from the government. - Financial Mail on Sunday

Consulting giant Alvarez & Marsal believes the business could fetch between $16-18bn if it pursued a stock market listing. At a presentation in Portugal, company executives noted how rival AlixPartners had hired Goldman Sachs to help it sell a stake. One of A&M's patriarchs, Bryan Marsal, believed that fast-growing Alix might fetch $8bn. - The Sunday Times

Shein has hiked its prices for shoppers in the US by as much as 377% in order to compensate for the tariffs imposed on it by Donald Trump. The fast-fashion giant, whose goods come mostly from China, imposed the increases on Friday. As a result, shoppers in the States will have to pay more than twice the amount of British shoppers. - The Sunday Telegraph

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Höfner, Sotheby's, Christie's
(Sharecast News) - Ministers and senior MPs have warned that the UK's agreements with Donald Trump are "built on sand" after the Guardian established that the deal to avoid drug tariffs has no underlying text beyond limited headline terms. The "milestone" US-UK deal announced this month on pharmaceuticals, which will mean the NHS pays more for medicines in exchange for a promise of zero tariffs on the industry, still lacks a legal footing beyond top lines contained in two government press releases. - Guardian
Wednesday newspaper round-up: Grangemouth ethylene plant, Warner Bros, ChatGPT
(Sharecast News) - Jim Ratcliffe's chemicals company Ineos has been granted £120m of government funding to help save the UK's last ethylene plant at Grangemouth, in a deal expected to protect more than 500 jobs. The investment in the Scottish plant was necessary to preserve a vital part of the country's chemicals infrastructure, the UK government said. The ethylene produced there was essential for medical-grade plastics production, water treatment and in aerospace and car-building, it added. - Guardian
Tuesday newspaper round-up: Nissan, Morrisons, Ford
(Sharecast News) - Nissan has started the production of its latest electric car in Sunderland, a crucial step in the UK automotive industry's transition away from petrol and diesel. The Japanese manufacturer will launch the third generation of the Leaf on Tuesday, which was the first mass-market battery electric car to be built in the UK. Nissan has made 282,704 Leaf models at the north-east England plant so far. - Guardian
Monday newspaper round-up: Cryptocurrencies, jobs downturn, Cycle Pharma
(Sharecast News) - Cryptocurrencies will be regulated in a similar way to other financial products under legislation coming into force in 2027. The Treasury is drawing up rules that will require crypto companies to meet a set of standards overseen by the Financial Conduct Authority (FCA). Ministers have sought to overhaul the crypto market, which has ballooned in popularity as a way of investing money and making payments. Cryptocurrencies have not been subject to the same regulation as traditional financial products such as stocks and shares, which means that in many cases consumers do not enjoy the same level of protection. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.